Thomas Tassin

3PUBLICATIONS

11CO-AUTHORS

Medical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 17, 2026

Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry.

Pageof 1

Frequent Collaborators

2 joint publications

Benjamin Lebecque

1 joint publications

Amine Belhabri

1 joint publications

Urbain Tauveron-Jalenques

1 joint publications

Emmanuelle Tavernier

1 joint publications

Gaspar Requena Aspas

1 joint publications

Mauricette Michallet

1 joint publications

Mathieu Meunier

1 joint publications

Samy Chraibi

1 joint publications

Emmanuel Beillard

1 joint publications

Pascale Flandrin

Frequent Collaborators

2 joint publications

Benjamin Lebecque

1 joint publications

Amine Belhabri

1 joint publications

Urbain Tauveron-Jalenques

1 joint publications

Emmanuelle Tavernier